London · Delayed Price · Currency is GBP · Price in GBX Regulus Therapeutics Statistics
Total Valuation
Bodycote has a market cap or net worth of GBP 1.11 billion. The enterprise value is 1.28 billion.
| Market Cap | 1.11B |
| Enterprise Value | 1.28B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Oct 2, 2025 |
Share Statistics
Bodycote has 176.35 million shares outstanding. The number of shares has decreased by -4.15% in one year.
| Current Share Class | 176.35M |
| Shares Outstanding | 176.35M |
| Shares Change (YoY) | -4.15% |
| Shares Change (QoQ) | -3.17% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 98.47% |
| Float | 174.31M |
Valuation Ratios
The trailing PE ratio is 40.06 and the forward PE ratio is 13.05. Bodycote's PEG ratio is 2.50.
| PE Ratio | 40.06 |
| Forward PE | 13.05 |
| PS Ratio | 1.52 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | 15.71 |
| P/OCF Ratio | 7.54 |
| PEG Ratio | 2.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.02, with an EV/FCF ratio of 18.15.
| EV / Earnings | 44.99 |
| EV / Sales | 1.76 |
| EV / EBITDA | 7.02 |
| EV / EBIT | 12.59 |
| EV / FCF | 18.15 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.30.
| Current Ratio | 0.74 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.05 |
| Debt / FCF | 2.71 |
| Interest Coverage | 15.86 |
Financial Efficiency
Return on equity (ROE) is 4.18% and return on invested capital (ROIC) is 7.31%.
| Return on Equity (ROE) | 4.18% |
| Return on Assets (ROA) | 5.81% |
| Return on Invested Capital (ROIC) | 7.31% |
| Return on Capital Employed (ROCE) | 13.69% |
| Revenue Per Employee | 166,042 |
| Profits Per Employee | 6,485 |
| Employee Count | 4,379 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 21.61 |
Taxes
In the past 12 months, Bodycote has paid 9.80 million in taxes.
| Income Tax | 9.80M |
| Effective Tax Rate | 25.26% |
Stock Price Statistics
The stock price has decreased by -10.17% in the last 52 weeks. The beta is 1.03, so Bodycote's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -10.17% |
| 50-Day Moving Average | 582.00 |
| 200-Day Moving Average | 589.24 |
| Relative Strength Index (RSI) | 61.46 |
| Average Volume (20 Days) | 208,819 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bodycote had revenue of GBP 727.10 million and earned 28.40 million in profits. Earnings per share was 0.16.
| Revenue | 727.10M |
| Gross Profit | 100.50M |
| Operating Income | 101.50M |
| Pretax Income | 38.80M |
| Net Income | 28.40M |
| EBITDA | 168.90M |
| EBIT | 101.50M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 20.20 million in cash and 190.50 million in debt, giving a net cash position of -170.30 million or -0.97 per share.
| Cash & Cash Equivalents | 20.20M |
| Total Debt | 190.50M |
| Net Cash | -170.30M |
| Net Cash Per Share | -0.97 |
| Equity (Book Value) | 641.00M |
| Book Value Per Share | 3.62 |
| Working Capital | -80.80M |
Cash Flow
In the last 12 months, operating cash flow was 146.70 million and capital expenditures -76.30 million, giving a free cash flow of 70.40 million.
| Operating Cash Flow | 146.70M |
| Capital Expenditures | -76.30M |
| Free Cash Flow | 70.40M |
| FCF Per Share | 0.40 |
Margins
Gross margin is 13.82%, with operating and profit margins of 13.96% and 3.91%.
| Gross Margin | 13.82% |
| Operating Margin | 13.96% |
| Pretax Margin | 5.34% |
| Profit Margin | 3.91% |
| EBITDA Margin | 23.23% |
| EBIT Margin | 13.96% |
| FCF Margin | 9.68% |
Dividends & Yields
This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 3.67%.
| Dividend Per Share | 0.23 |
| Dividend Yield | 3.67% |
| Dividend Growth (YoY) | 0.44% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 145.77% |
| Buyback Yield | 4.15% |
| Shareholder Yield | 7.82% |
| Earnings Yield | 2.57% |
| FCF Yield | 6.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 9, 2008. It was a reverse split with a ratio of 0.57895.
| Last Split Date | Dec 9, 2008 |
| Split Type | Reverse |
| Split Ratio | 0.57895 |
Scores
Bodycote has an Altman Z-Score of 2.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 4 |